Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32008| Title: | Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper. | Austin Authors: | Villani, Flavio;Cianci, Vittoria;Di Bonaventura, Carlo;Di Gennaro, Giancarlo;Galimberti, Carlo Andrea;Guerrini, Renzo;La Neve, Angela;Mecarelli, Oriano;Pietrafusa, Nicola;Specchio, Nicola;Vigevano, Federico;Perucca, Emilio | Affiliation: | Division of Clinical Neurophysiology and Epilepsy Center, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Regional Epilepsy Centre, Great Metropolitan Hospital, Bianchi-Melacrino Morelli, Reggio, Italy. Epilepsy Centre, Department of Human Neurosciences, "Sapienza" University of Rome, Rome, Italy. NEUROMED, IRCCS, Pozzilli, Isernia, Italy. Epilepsy Center, Mondino Foundation, IRCCS, Pavia, Italy. Neuroscience Department, Children's Hospital A. Meyer-University of Florence, Italy. Department of Basic Medical Sciences, Neurosciences and Sense Organs, University Hospital of Bari "A. Moro", Bari, Italy. Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy. Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy, Department of Medicine (Austin Health), University of Melbourne, and Department of Neuroscience, Monash University, Melbourne, Victoria, Australia. Medicine (University of Melbourne) |
Issue Date: | 20-Jan-2023 | Date: | 2023 | Publication information: | Expert Review of Neurotherapeutics 2023 | Abstract: | Cenobamate is a new antiseizure medication (ASM) recently introduced in the USA for the treatment of adults with focal-onset seizures. In March 2021, the European Commission authorized its use for the adjunctive treatment of focal-onset seizures with or without secondary generalization (focal seizures with or without progression to bilateral tonic-clonic seizures, according to current ILAE terminology) in adults with epilepsy not adequately controlled despite the treatment with at least two ASMs. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/32008 | DOI: | 10.1080/14737175.2023.2171291 | ORCID: | 0000-0002-7272-7079 |
Journal: | Expert Review of Neurotherapeutics | PubMed URL: | 36662573 | ISSN: | 1744-8360 | Type: | Journal Article | Subjects: | Cenobamate drug resistance epilepsy focal seizures |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.